These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 39304574)

  • 1. Chemokine Receptor 4-Targeted PET/CT with [
    Yang Q; Zhang F; Hao Z; Zhuang J; Huo L
    Mol Imaging Biol; 2024 Dec; 26(6):986-994. PubMed ID: 39304574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    He L; Yang Y; Cao X; Zhu X; Liu N; Chen X; Zhang J; Zhang W
    Theranostics; 2024; 14(19):7281-7291. PubMed ID: 39659571
    [No Abstract]   [Full Text] [Related]  

  • 3. Exploring the Potential Value of [ 68 Ga]Ga-FAPI-46 PET/CT for Molecular Assessment of Fibroblast Activation in Interstitial Lung Disease : A Single-Center Pilot Study.
    Bahtouee M; Jafari E; Khazaei M; Aram N; Amini A; Jokar N; Ahmadzadehfar H; Gholamrezanezhad A; Assadi M
    Clin Nucl Med; 2025 Jan; 50(1):e17-e25. PubMed ID: 39466620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [
    Michalski K; Kosmala A; Hartrampf PE; Heinrich M; Serfling SE; Schlötelburg W; Buck AK; Meining A; Werner RA; Weich A
    J Nucl Med; 2024 Dec; 65(12):1899-1903. PubMed ID: 39477500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-Like Peptide-1 Receptor-Targeted PET/CT With 68 Ga-HBED-CC-Exendin-4 in Localizing Insulinoma : A Head-to-Head Comparison to 68 Ga-NOTA-Exendin-4.
    Li L; Wang G; Wang J; Ma H; Chen J; Wang R; Pan Q; Hong H; Jin W; Kung HF; Zhu L; Luo Y; Zhu Z
    Clin Nucl Med; 2025 Jan; 50(1):38-43. PubMed ID: 39499011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial peptide LyeTx I mn∆K labeled with
    Fuscaldi LL; Durante ACR; Dapueto R; Reyes AL; Paolino A; Savio E; Malavolta L; de Lima ME; Fernandes SOA; Cardoso VN; de Barboza MF
    Nucl Med Biol; 2024; 138-139():108966. PubMed ID: 39426352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [
    Levi J; Das M; Vasanawala MS; Behl D; Pomper M; Forde PM; Nakajima E; Sayre J; Shen B; Cabrera H; Del Mar N; Gullen M; Pierini M; Cox L; Lokre O; Perk T; Chae HD
    J Nucl Med; 2024 Dec; 65(12):1869-1875. PubMed ID: 39448270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [
    Pabst KM; Mei R; Lückerath K; Hadaschik BA; Kesch C; Rawitzer J; Kessler L; Bodensieck LS; Hamacher R; Pomykala KL; Fanti S; Herrmann K; Fendler WP
    Eur J Nucl Med Mol Imaging; 2024 Dec; 52(1):342-353. PubMed ID: 39207485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of [
    Lou K; Wang J; He H; Wang Y; Mi Y; Li W; Chen L; Zhang Y; Mao Y; Lin J; Fu H; Yu C
    J Nucl Med; 2024 Dec; 65(12):1884-1890. PubMed ID: 39542699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Posttherapy 4- and 24-Hour [
    Swiha M; Pathmanandavel S; Papa N; Sabahi Z; Li S; Zheng A; Khan S; Ayers M; Sharma S; Crumbaker M; Nguyen A; Chan L; Ayati N; Emmett L
    J Nucl Med; 2024 Dec; 65(12):1939-1944. PubMed ID: 39477497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo validation of
    Renard I; Domarkas J; Poty S; Burke BP; Roberts DP; Goze C; Denat F; Cawthorne CJ; Archibald SJ
    Nucl Med Biol; 2023; 120-121():108335. PubMed ID: 37068392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagenase injection versus limited fasciectomy surgery to treat Dupuytren's contracture in adult patients in the UK: DISC, a non-inferiority RCT and economic evaluation.
    Dias J; Tharmanathan P; Arundel C; Welch C; Wu Q; Leighton P; Armaou M; Corbacho B; Johnson N; James S; Cooke J; Bainbridge C; Craigen M; Warwick D; Brady S; Flett L; Jones J; Knowlson C; Watson M; Keding A; Hewitt C; Torgerson D
    Health Technol Assess; 2024 Dec; 28(78):1-262. PubMed ID: 39644138
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Ruan D; Sun J; Han C; Cai J; Yu L; Zhao L; Pang Y; Zuo C; Sun L; Wang Z; Tan G; Qu X; Chen H
    Theranostics; 2024; 14(18):6935-6946. PubMed ID: 39629119
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of myeloma-associated osteolytic bone lesions with energy-integrating and photon-counting detector CT.
    Grözinger M; Wennmann M; Sawall S; Wehrse E; Sedaghat S; Neelsen C; Bauer F; Goldschmidt H; Weru V; Ziener CH; Kopp-Schneider A; Schlemmer HP; Rotkopf LT
    Radiologie (Heidelb); 2024 Nov; 64(Suppl 1):24-31. PubMed ID: 39020050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daratumumab-based regimen for newly diagnosed multiple myeloma patients with paraskeletal plasmacytomas: a retrospective study in a single center.
    Xu S; Chen W; Li Y
    Hematology; 2024 Dec; 29(1):2431958. PubMed ID: 39589101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the application value of SUV in quantitative SPECT/CT for diagnosing benign and malignant bone lesions.
    Guo J; Chen C; Xiong L; Xiao L; Wei Y; Sun C
    Hell J Nucl Med; 2024 Dec; ():. PubMed ID: 39644271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Different Diagnostic Criteria of 68Ga-Pentixafor PET/CT for the Classification of Primary Aldosteronism.
    Zhang X; Song Y; Jing Y; Hu J; Shen H; Zhang A; He W; Feng Z; Yang Y; Pang H; Li Q; Yang S;
    J Clin Endocrinol Metab; 2024 Nov; ():. PubMed ID: 39626105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline Nodal Status on
    Hofman MS; Kasivisvanathan V; Link E; Buteau J; Roberts MJ; Francis RJ; Tang C; Vela I; Thomas P; Rutherford N; Martin JM; Frydenberg M; Shakher R; Wong LM; Taubman K; Ting Lee S; Hsiao E; Roach P; Nottage M; Kirkwood I; Hayne D; Iravani A; Williams S; O'Brien J; Lawrentschuk N; Murphy DG
    Eur Urol Oncol; 2024 Nov; ():. PubMed ID: 39613566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.